Council for International Organizations of Medical Sciences.
40 works on record
Works
Biomedical Research Ethics
2000
Benefit Risk Balance for Marketed Drugs
1998
Genetics, Ethics and Human Values
1991
Brain mechanisms and learning
1961
International Reporting of Adverse Drug Reactions : Final Report of the CIOMS Working Group
Biomedical research involving animals
Guidelines for Preparing Core Clinical-Safety Information on Drugs
1999
Reporting Adverse Drug Reactions
1999
Harmonizing the use of adverse-drug-reaction terms
1996
International Guidelines for Ethical Review of Epidemiological Studies
1991
Health Policy, Ethics and Human Values
1989
Calendar of Congresses of Medical Sciences
1989
Organization, activities, members
1985
International Guiding Principles for Biomedical Research Involving Animals
1985
Principles of Medical Ethics Relevant to the Protection of Prisoners Against Torture (Cioms Nonserial)
1984
Safety requirements for the first use of new drugs and diagnostic agents in man
1983
Health for All (CIOMS Round Table Proceedings)
1983
Health for All - a Challenge to Research in Health Manpower Development (CIOMS Publication)
1983
Human experimentation and medical ethics
1982
Krankheiten der Harnorgane und der männlichen Geschlechtsorgane
1976
Nomenclature internationale provisoire des maladies du système cardio-vasculaire
1974
CIOMS 9th General Assembly =
1973
The planning of international medical meetings
1967
New trends in basic lymphology
1967
Abnormal haemoglobins in Africa
1965
Immunological methods
1964
Infection in hospitals
1963
The transparency of the cornea
1960
The biochemical response to injury
1960
Oxygen supply to the human fetus
1959
Oxygen supply to the human foetus
1959
Methods of geographical pathology
1959
Abnormal haemoglobins
1959
Bibliography of international congresses of medical sciences
1958
The planning of international meetings
1957
Physiopathology of the reticulo-endothelial system
1957
Glaucoma
1955
Brain mechanisms and consciousness
1954
Anoxia of the new-born infant
1953
Monitoring and Assessment of Adverse Drug Effects